Global Everolimus Eluting Stent Market Growth 2024-2030

July 2024 | 76 pages | ID: G7AADD2CA457EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Ivolimus drug eluting stents are typically composed of a metal scaffold and a drug coating covering the surface of the scaffold. Metal brackets are usually made of biocompatible materials, such as stainless steel, chromium cobalt alloy, etc. The drug coating of the stent contains Everolimus, an immunosuppressive drug. The drug will be released onto the vascular wall around the stent, thereby inhibiting intimal hyperplasia and reducing the risk of vascular restenosis. Ivolimus drug eluting stents work in two ways: metal stents provide mechanical support to maintain vascular patency; The drug coating releases everolimus, inhibits vascular intimal hyperplasia, and reduces the possibility of vascular restenosis.

The global Everolimus Eluting Stent market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Everolimus Eluting Stent Industry Forecast” looks at past sales and reviews total world Everolimus Eluting Stent sales in 2023, providing a comprehensive analysis by region and market sector of projected Everolimus Eluting Stent sales for 2024 through 2030. With Everolimus Eluting Stent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Everolimus Eluting Stent industry.

This Insight Report provides a comprehensive analysis of the global Everolimus Eluting Stent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Everolimus Eluting Stent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Everolimus Eluting Stent market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Everolimus Eluting Stent and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Everolimus Eluting Stent.

United States market for Everolimus Eluting Stent is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Everolimus Eluting Stent is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Everolimus Eluting Stent is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Everolimus Eluting Stent players cover Boston Scientific, Abbott, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Everolimus Eluting Stent market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• PLGA Polymer Coating
• Fluoropolymer Coating

Segmentation by Application:

• Hospital
• Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Boston Scientific
• Abbott

Key Questions Addressed in this Report

What is the 10-year outlook for the global Everolimus Eluting Stent market?

What factors are driving Everolimus Eluting Stent market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Everolimus Eluting Stent market opportunities vary by end market size?

How does Everolimus Eluting Stent break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Everolimus Eluting Stent Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for Everolimus Eluting Stent by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for Everolimus Eluting Stent by Country/Region, 2019, 2023 & 2030
2.2 Everolimus Eluting Stent Segment by Type
  2.2.1 PLGA Polymer Coating
  2.2.2 Fluoropolymer Coating
2.3 Everolimus Eluting Stent Sales by Type
  2.3.1 Global Everolimus Eluting Stent Sales Market Share by Type (2019-2024)
  2.3.2 Global Everolimus Eluting Stent Revenue and Market Share by Type (2019-2024)
  2.3.3 Global Everolimus Eluting Stent Sale Price by Type (2019-2024)
2.4 Everolimus Eluting Stent Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Others
2.5 Everolimus Eluting Stent Sales by Application
  2.5.1 Global Everolimus Eluting Stent Sale Market Share by Application (2019-2024)
  2.5.2 Global Everolimus Eluting Stent Revenue and Market Share by Application (2019-2024)
  2.5.3 Global Everolimus Eluting Stent Sale Price by Application (2019-2024)

3 GLOBAL BY COMPANY

3.1 Global Everolimus Eluting Stent Breakdown Data by Company
  3.1.1 Global Everolimus Eluting Stent Annual Sales by Company (2019-2024)
  3.1.2 Global Everolimus Eluting Stent Sales Market Share by Company (2019-2024)
3.2 Global Everolimus Eluting Stent Annual Revenue by Company (2019-2024)
  3.2.1 Global Everolimus Eluting Stent Revenue by Company (2019-2024)
  3.2.2 Global Everolimus Eluting Stent Revenue Market Share by Company (2019-2024)
3.3 Global Everolimus Eluting Stent Sale Price by Company
3.4 Key Manufacturers Everolimus Eluting Stent Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Everolimus Eluting Stent Product Location Distribution
  3.4.2 Players Everolimus Eluting Stent Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR EVEROLIMUS ELUTING STENT BY GEOGRAPHIC REGION

4.1 World Historic Everolimus Eluting Stent Market Size by Geographic Region (2019-2024)
  4.1.1 Global Everolimus Eluting Stent Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global Everolimus Eluting Stent Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Everolimus Eluting Stent Market Size by Country/Region (2019-2024)
  4.2.1 Global Everolimus Eluting Stent Annual Sales by Country/Region (2019-2024)
  4.2.2 Global Everolimus Eluting Stent Annual Revenue by Country/Region (2019-2024)
4.3 Americas Everolimus Eluting Stent Sales Growth
4.4 APAC Everolimus Eluting Stent Sales Growth
4.5 Europe Everolimus Eluting Stent Sales Growth
4.6 Middle East & Africa Everolimus Eluting Stent Sales Growth

5 AMERICAS

5.1 Americas Everolimus Eluting Stent Sales by Country
  5.1.1 Americas Everolimus Eluting Stent Sales by Country (2019-2024)
  5.1.2 Americas Everolimus Eluting Stent Revenue by Country (2019-2024)
5.2 Americas Everolimus Eluting Stent Sales by Type (2019-2024)
5.3 Americas Everolimus Eluting Stent Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Everolimus Eluting Stent Sales by Region
  6.1.1 APAC Everolimus Eluting Stent Sales by Region (2019-2024)
  6.1.2 APAC Everolimus Eluting Stent Revenue by Region (2019-2024)
6.2 APAC Everolimus Eluting Stent Sales by Type (2019-2024)
6.3 APAC Everolimus Eluting Stent Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Everolimus Eluting Stent by Country
  7.1.1 Europe Everolimus Eluting Stent Sales by Country (2019-2024)
  7.1.2 Europe Everolimus Eluting Stent Revenue by Country (2019-2024)
7.2 Europe Everolimus Eluting Stent Sales by Type (2019-2024)
7.3 Europe Everolimus Eluting Stent Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Everolimus Eluting Stent by Country
  8.1.1 Middle East & Africa Everolimus Eluting Stent Sales by Country (2019-2024)
  8.1.2 Middle East & Africa Everolimus Eluting Stent Revenue by Country (2019-2024)
8.2 Middle East & Africa Everolimus Eluting Stent Sales by Type (2019-2024)
8.3 Middle East & Africa Everolimus Eluting Stent Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Everolimus Eluting Stent
10.3 Manufacturing Process Analysis of Everolimus Eluting Stent
10.4 Industry Chain Structure of Everolimus Eluting Stent

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Everolimus Eluting Stent Distributors
11.3 Everolimus Eluting Stent Customer

12 WORLD FORECAST REVIEW FOR EVEROLIMUS ELUTING STENT BY GEOGRAPHIC REGION

12.1 Global Everolimus Eluting Stent Market Size Forecast by Region
  12.1.1 Global Everolimus Eluting Stent Forecast by Region (2025-2030)
  12.1.2 Global Everolimus Eluting Stent Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Everolimus Eluting Stent Forecast by Type (2025-2030)
12.7 Global Everolimus Eluting Stent Forecast by Application (2025-2030)

13 KEY PLAYERS ANALYSIS

13.1 Boston Scientific
  13.1.1 Boston Scientific Company Information
  13.1.2 Boston Scientific Everolimus Eluting Stent Product Portfolios and Specifications
  13.1.3 Boston Scientific Everolimus Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 Boston Scientific Main Business Overview
  13.1.5 Boston Scientific Latest Developments
13.2 Abbott
  13.2.1 Abbott Company Information
  13.2.2 Abbott Everolimus Eluting Stent Product Portfolios and Specifications
  13.2.3 Abbott Everolimus Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2024)
  13.2.4 Abbott Main Business Overview
  13.2.5 Abbott Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Everolimus Eluting Stent Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Everolimus Eluting Stent Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of PLGA Polymer Coating
Table 4. Major Players of Fluoropolymer Coating
Table 5. Global Everolimus Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 6. Global Everolimus Eluting Stent Sales Market Share by Type (2019-2024)
Table 7. Global Everolimus Eluting Stent Revenue by Type (2019-2024) & ($ million)
Table 8. Global Everolimus Eluting Stent Revenue Market Share by Type (2019-2024)
Table 9. Global Everolimus Eluting Stent Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Everolimus Eluting Stent Sale by Application (2019-2024) & (K Units)
Table 11. Global Everolimus Eluting Stent Sale Market Share by Application (2019-2024)
Table 12. Global Everolimus Eluting Stent Revenue by Application (2019-2024) & ($ million)
Table 13. Global Everolimus Eluting Stent Revenue Market Share by Application (2019-2024)
Table 14. Global Everolimus Eluting Stent Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Everolimus Eluting Stent Sales by Company (2019-2024) & (K Units)
Table 16. Global Everolimus Eluting Stent Sales Market Share by Company (2019-2024)
Table 17. Global Everolimus Eluting Stent Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Everolimus Eluting Stent Revenue Market Share by Company (2019-2024)
Table 19. Global Everolimus Eluting Stent Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Everolimus Eluting Stent Producing Area Distribution and Sales Area
Table 21. Players Everolimus Eluting Stent Products Offered
Table 22. Everolimus Eluting Stent Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Everolimus Eluting Stent Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Everolimus Eluting Stent Sales Market Share Geographic Region (2019-2024)
Table 27. Global Everolimus Eluting Stent Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Everolimus Eluting Stent Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Everolimus Eluting Stent Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Everolimus Eluting Stent Sales Market Share by Country/Region (2019-2024)
Table 31. Global Everolimus Eluting Stent Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Everolimus Eluting Stent Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Everolimus Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 34. Americas Everolimus Eluting Stent Sales Market Share by Country (2019-2024)
Table 35. Americas Everolimus Eluting Stent Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Everolimus Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 37. Americas Everolimus Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 38. APAC Everolimus Eluting Stent Sales by Region (2019-2024) & (K Units)
Table 39. APAC Everolimus Eluting Stent Sales Market Share by Region (2019-2024)
Table 40. APAC Everolimus Eluting Stent Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Everolimus Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 42. APAC Everolimus Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 43. Europe Everolimus Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 44. Europe Everolimus Eluting Stent Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Everolimus Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 46. Europe Everolimus Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 47. Middle East & Africa Everolimus Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 48. Middle East & Africa Everolimus Eluting Stent Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Everolimus Eluting Stent Sales by Type (2019-2024) & (K Units)
Table 50. Middle East & Africa Everolimus Eluting Stent Sales by Application (2019-2024) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Everolimus Eluting Stent
Table 52. Key Market Challenges & Risks of Everolimus Eluting Stent
Table 53. Key Industry Trends of Everolimus Eluting Stent
Table 54. Everolimus Eluting Stent Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Everolimus Eluting Stent Distributors List
Table 57. Everolimus Eluting Stent Customer List
Table 58. Global Everolimus Eluting Stent Sales Forecast by Region (2025-2030) & (K Units)
Table 59. Global Everolimus Eluting Stent Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Everolimus Eluting Stent Sales Forecast by Country (2025-2030) & (K Units)
Table 61. Americas Everolimus Eluting Stent Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Everolimus Eluting Stent Sales Forecast by Region (2025-2030) & (K Units)
Table 63. APAC Everolimus Eluting Stent Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Everolimus Eluting Stent Sales Forecast by Country (2025-2030) & (K Units)
Table 65. Europe Everolimus Eluting Stent Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Everolimus Eluting Stent Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Middle East & Africa Everolimus Eluting Stent Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Everolimus Eluting Stent Sales Forecast by Type (2025-2030) & (K Units)
Table 69. Global Everolimus Eluting Stent Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Everolimus Eluting Stent Sales Forecast by Application (2025-2030) & (K Units)
Table 71. Global Everolimus Eluting Stent Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Boston Scientific Basic Information, Everolimus Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 73. Boston Scientific Everolimus Eluting Stent Product Portfolios and Specifications
Table 74. Boston Scientific Everolimus Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Boston Scientific Main Business
Table 76. Boston Scientific Latest Developments
Table 77. Abbott Basic Information, Everolimus Eluting Stent Manufacturing Base, Sales Area and Its Competitors
Table 78. Abbott Everolimus Eluting Stent Product Portfolios and Specifications
Table 79. Abbott Everolimus Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Abbott Main Business
Table 81. Abbott Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Everolimus Eluting Stent
Figure 2. Everolimus Eluting Stent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Everolimus Eluting Stent Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Everolimus Eluting Stent Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Everolimus Eluting Stent Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Everolimus Eluting Stent Sales Market Share by Country/Region (2023)
Figure 10. Everolimus Eluting Stent Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of PLGA Polymer Coating
Figure 12. Product Picture of Fluoropolymer Coating
Figure 13. Global Everolimus Eluting Stent Sales Market Share by Type in 2023
Figure 14. Global Everolimus Eluting Stent Revenue Market Share by Type (2019-2024)
Figure 15. Everolimus Eluting Stent Consumed in Hospital
Figure 16. Global Everolimus Eluting Stent Market: Hospital (2019-2024) & (K Units)
Figure 17. Everolimus Eluting Stent Consumed in Clinic
Figure 18. Global Everolimus Eluting Stent Market: Clinic (2019-2024) & (K Units)
Figure 19. Everolimus Eluting Stent Consumed in Others
Figure 20. Global Everolimus Eluting Stent Market: Others (2019-2024) & (K Units)
Figure 21. Global Everolimus Eluting Stent Sale Market Share by Application (2023)
Figure 22. Global Everolimus Eluting Stent Revenue Market Share by Application in 2023
Figure 23. Everolimus Eluting Stent Sales by Company in 2023 (K Units)
Figure 24. Global Everolimus Eluting Stent Sales Market Share by Company in 2023
Figure 25. Everolimus Eluting Stent Revenue by Company in 2023 ($ millions)
Figure 26. Global Everolimus Eluting Stent Revenue Market Share by Company in 2023
Figure 27. Global Everolimus Eluting Stent Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Everolimus Eluting Stent Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Everolimus Eluting Stent Sales 2019-2024 (K Units)
Figure 30. Americas Everolimus Eluting Stent Revenue 2019-2024 ($ millions)
Figure 31. APAC Everolimus Eluting Stent Sales 2019-2024 (K Units)
Figure 32. APAC Everolimus Eluting Stent Revenue 2019-2024 ($ millions)
Figure 33. Europe Everolimus Eluting Stent Sales 2019-2024 (K Units)
Figure 34. Europe Everolimus Eluting Stent Revenue 2019-2024 ($ millions)
Figure 35. Middle East & Africa Everolimus Eluting Stent Sales 2019-2024 (K Units)
Figure 36. Middle East & Africa Everolimus Eluting Stent Revenue 2019-2024 ($ millions)
Figure 37. Americas Everolimus Eluting Stent Sales Market Share by Country in 2023
Figure 38. Americas Everolimus Eluting Stent Revenue Market Share by Country (2019-2024)
Figure 39. Americas Everolimus Eluting Stent Sales Market Share by Type (2019-2024)
Figure 40. Americas Everolimus Eluting Stent Sales Market Share by Application (2019-2024)
Figure 41. United States Everolimus Eluting Stent Revenue Growth 2019-2024 ($ millions)
Figure 42. Canada Everolimus Eluting Stent Revenue Growth 2019-2024 ($ millions)
Figure 43. Mexico Everolimus Eluting Stent Revenue Growth 2019-2024 ($ millions)
Figure 44. Brazil Everolimus Eluting Stent Revenue Growth 2019-2024 ($ millions)
Figure 45. APAC Everolimus Eluting Stent Sales Market Share by Region in 2023
Figure 46. APAC Everolimus Eluting Stent Revenue Market Share by Region (2019-2024)
Figure 47. APAC Everolimus Eluting Stent Sales Market Share by Type (2019-2024)
Figure 48. APAC Everolimus Eluting Stent Sales Market Share by Application (2019-2024)
Figure 49. China Everolimus Eluting Stent Revenue Growth 2019-2024 ($ millions)
Figure 50. Japan Everolimus Eluting Stent Revenue Growth 2019-2024 ($ millions)
Figure 51. South Korea Everolimus Eluting Stent Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast Asia Everolimus Eluting Stent Revenue Growth 2019-2024 ($ millions)
Figure 53. India Everolimus Eluting Stent Revenue Growth 2019-2024 ($ millions)
Figure 54. Australia Everolimus Eluting Stent Revenue Growth 2019-2024 ($ millions)
Figure 55. China Taiwan Everolimus Eluting Stent Revenue Growth 2019-2024 ($ millions)
Figure 56. Europe Everolimus Eluting Stent Sales Market Share by Country in 2023
Figure 57. Europe Everolimus Eluting Stent Revenue Market Share by Country (2019-2024)
Figure 58. Europe Everolimus Eluting Stent Sales Market Share by Type (2019-2024)
Figure 59. Europe Everolimus Eluting Stent Sales Market Share by Application (2019-2024)
Figure 60. Germany Everolimus Eluting Stent Revenue Growth 2019-2024 ($ millions)
Figure 61. France Everolimus Eluting Stent Revenue Growth 2019-2024 ($ millions)
Figure 62. UK Everolimus Eluting Stent Revenue Growth 2019-2024 ($ millions)
Figure 63. Italy Everolimus Eluting Stent Revenue Growth 2019-2024 ($ millions)
Figure 64. Russia Everolimus Eluting Stent Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & Africa Everolimus Eluting Stent Sales Market Share by Country (2019-2024)
Figure 66. Middle East & Africa Everolimus Eluting Stent Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Everolimus Eluting Stent Sales Market Share by Application (2019-2024)
Figure 68. Egypt Everolimus Eluting Stent Revenue Growth 2019-2024 ($ millions)
Figure 69. South Africa Everolimus Eluting Stent Revenue Growth 2019-2024 ($ millions)
Figure 70. Israel Everolimus Eluting Stent Revenue Growth 2019-2024 ($ millions)
Figure 71. Turkey Everolimus Eluting Stent Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC Countries Everolimus Eluting Stent Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Everolimus Eluting Stent in 2023
Figure 74. Manufacturing Process Analysis of Everolimus Eluting Stent
Figure 75. Industry Chain Structure of Everolimus Eluting Stent
Figure 76. Channels of Distribution
Figure 77. Global Everolimus Eluting Stent Sales Market Forecast by Region (2025-2030)
Figure 78. Global Everolimus Eluting Stent Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Everolimus Eluting Stent Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Everolimus Eluting Stent Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Everolimus Eluting Stent Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Everolimus Eluting Stent Revenue Market Share Forecast by Application (2025-2030)